ERG-344

N/A

Report date: 2023/04/07 16:11:15
NME

Base Information

Drug NameERG-344
Drug Alias NameERG-344
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCis-aconitate decarboxylase inhibitors
TargetsCis-aconitate decarboxylase
Therapy Area/IndicationsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesErgon Pharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesErgon Pharmaceuticals LLC
Inactive CompaniesN/A
Active IndicationsColonic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A